BioAge is a clinical-stage biotechnology company developing novel therapies for obesity and metabolic diseases discovered by harnessing the biology of aging. Lassen Therapeutics is a biotechnology company developing first-in-class monoclonal antibodies (mAb) targeting the IL-11 receptor (IL-11R), a central mediator of fibrosis and inflammation. OrsoBio is a biopharmaceutical company developing oral treatments for metabolic disorders. Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare liver diseases. NOCD is a health solutions company providing a digital platform to identify and manage obsessive-compulsive disorder.